Medical Decision-Making Processes and Online Behaviors Among Cannabis Dispensary Staff

Substance Abuse: Research and Treatment

Volumn 11, Issue , 2017, Pages

  Peiper, Nicholas C ^a   Gourdet, Camille ^a   Meinhofer, Angélica ^a   Reiman, Amanda ^b   Reggente, Nicco ^c  

^a RTI INTERNATIONAL   (United States)

^b PUBLIC HEALTH INSTITUTE   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

budtender; Cannabis; dispensary; Internet; marijuana; medical decision making

Indexed keywords

CANNABIS;

ADULT; ARTICLE; BUDTENDER; CROSS-SECTIONAL STUDY; E-MAIL; FEMALE; HUMAN; INTERNET; MALE; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MOBILE APPLICATION; OCCUPATION; SOCIAL MEDIA; STAFF TRAINING; TEXT MESSAGING;

EID: 85044679530     PISSN: None     EISSN: 11782218     Source Type: Journal    
DOI: 10.1177/1178221817725515     Document Type: Article

References (53)

1. National Conference of State Legislatures. State Medical Marijuana Laws as of April 21, 2017. http://www.ncsl.org/research/health/state-medical-marijuana-laws.aspx. Accessed July 4, 2017.
2. Reinarman C, Nunberg H, Lanthier F, Heddleston T., Who are medical marijuana patients? Population characteristics from nine California assessment clinics. J Psychoactive Drugs. 2011;43:128–135.
3. O’Connell TJ, Bou-Matar CB., Long term marijuana users seeking medical cannabis in California (2001-2007): demographics, social characteristics, patterns of cannabis and other drug use of 4117 applicants. Harm Reduct J. 2007:16.
4. Walsh Z, Callaway R, Belle-Isle L. Cannabis for therapeutic purposes: patient characteristics, access, and reasons for use. Int J Drug Policy. 2013;24:511–516.
5. Reiman A., Medical cannabis patients: patient profiles and health care utilization patterns. Complement Health Pract Rev. 2007;12:31–50.
6. Roy-Byrne P, Maynard C, Bumgardner K. Are medical marijuana users different from recreational users? The view from primary care. Am J Addict. 2015;24:599–606.
7. Reiman AE., Self-efficacy, social support and service integration at medical cannabis facilities in the San Francisco Bay area of California. Health Soc Care Community. 2008;16:31–41.
8. Janichek JL, Reiman A., Clinical service desires of medical cannabis patients. Harm Reduct J. 2012;9:12.
9. Carter GT, Javaher SP, Nguyen MH, Garret S, Carlini BH., Re-branding cannabis: the next generation of chronic pain medicine? Pain Manag. 2015;5:13–21.
10. Konkolÿ Thege B, Colman I, el-Guebaly N. Social judgments of behavioral versus substance-related addictions: a population-based study. Addict Behav. 2015;42:24–31.
11. Satterlund TD, Lee JP, Moore RS., Stigma among California’s medical marijuana patients. J Psychoactive Drugs. 2015;47:10–17.
12. Grella CE, Rodriguez L, Kim T., Patterns of medical marijuana use among individuals sampled from medical marijuana dispensaries in Los Angeles. J Psychoactive Drugs. 2014;46:263–272.
13. Kepple NJ, Mulholland E, Freisthler B, Schaper E., Correlates of amount spent on marijuana buds during a discrete purchase at medical marijuana dispensaries: results from a pilot study. J Psychoactive Drugs. 2016;48:50–55.
14. Bierut T, Krauss MJ, Sowles SJ, Cavazos-Rehg PA., Exploring marijuana advertising on Weedmaps, a popular online directory. Prev Sci. 2017;17:183–192.
15. Haug NA, Kieschnick D, Sottile JE, Babson KA, Vandrey R, Bonn-Miller MO., Training and practices of cannabis dispensary staff. Cannabis Cannabinoid Res. 2016;1:244–251.
16. Mackey TK, Liang BA., Global reach of direct-to-consumer advertising using social media for illicit online drug sales. J Med Internet Res. 2013;15:e105.
17. Fowler FJ, Gerstein BS, Barry MJ., How patient centered are medical decisions?: results of a national survey. JAMA Intern Med. 2013;173:1215–1221.
18. Massey PM., Where do U.S. adults who do not use the internet get health information? Examining digital health information disparities from 2008 to 2013. J Health Commun. 2016;21:118–124.
19. Glenn T, Monteith S., New measures of mental state and behavior based on data collected from sensors, smartphones, and the Internet. Curr Psychiatry Rep. 2014;16:523.
20. Miller PG, Sønderlund AL., Using the internet to research hidden populations of illicit drug users: a review. Addiction. 2010;105:1557–1567.
21. Watters JK, Biernacki P., Targeted sampling: options for the study of hidden populations. Soc Probl. 1989;36:416–430.
22. Moreau A, Carol L, Dedianne MC. What perceptions do patients have of decision making (DM)? Toward an integrative patient-centered care model. A qualitative study using focus-group interviews. Patient Educ Couns. 2012;87:206–211.
23. Bingham JB, Mitchell BW, Bishop DG, Allen NJ., Working for a higher purpose: a theoretical framework for commitment to organization-sponsored causes. Hum Resour Manage R. 2013;23:174–189.
24. Barry MJ, Edgman-Levitan S., Shared decision making—the pinnacle of patient-centered care. N Engl J Med. 2012;366:780–781.
25. Légaré F, Ratté S, Stacey D. Interventions for improving the adoption of shared decision making by healthcare professionals. Cochrane Database Syst Rev. 2010;5:CD006732.
26. Ramo DE, Popova L, Grana R, Zhao S, Chavez K., Cannabis mobile apps: a content analysis. JMIR Mhealth Uhealth. 2015;3:e81.
27. Cavazos-Rehg P, Krauss M, Grucza R, Bierut L., Characterizing the followers and tweets of a marijuana-focused Twitter handle. J Med Internet Res. 2014;16:e157.
28. Truth in advertising and marketing, Cal Bus. & Prof. Code § 26152.
29. Advertising; Required notice, Cal Bus. & Prof. Code § 2525.5.
30. Eysenbach G., Infodemiology and infoveillance: framework for an emerging set of public health informatics methods to analyze search, communication and publication behavior on the internet. J Med Internet Res. 2009;11:e11.
31. Caulkins JP, Kilmer B, MacCoun RJ, Pacula RL, Reuter P., Design considerations for legalizing cannabis: lessons inspired by analysis of California’s Proposition 19. Addiction. 2012;107:865–871.
32. Cavazos-Rehg P, Krauss M, Spitznagel E, Buckner-Petty S, Grucza R, Bierut L., Monitoring marijuana use and risk perceptions with Google Trends data. Drug Alcohol Depend. 2015;146:e242–e243.
33. Cavazos-Rehg PA, Sowles SJ, Krauss MJ, Agbonavbare V, Grucza R, Bierut L., A content analysis of tweets about high-potency marijuana. Drug Alcohol Depend. 2016;166:100–108.
34. Krauss MJ, Grucza RA, Bierut LJ, Cavazos-Rehg PA., “Get drunk. Smoke weed. Have fun.”: a content analysis of tweets about marijuana and alcohol. Am J Health Promot. 2017;31:200–208.
35. Adulteration of medical cannabis product; Manufacture, sale, delivery, holding, or receipt of adulterated medical cannabis product, Cal Bus. & Prof. Code § 19347.6.
36. Health and safety requirements for manufacture, production, and sale of marijuana products, Cal Bus. & Prof. Code § 26130.
37. Regulations governing licensing of commercial cultivation sites; Guidelines for use of pesticides; CEQA lead agency; Duties of specified state agencies; State cultivator license types, Cal Bus. & Prof. Code § 19332.
38. Certificate of analysis, Cal Bus. & Prof. Code § 19344.
39. Labeling and packaging requirements for marijuana and marijuana products, Cal Bus. & Prof. Code § 26120.
40. Packaging and labeling of medical cannabis and medical cannabis products, Cal Bus. & Prof. Code § 19347.
41. Davis KC, Allen J, Duke J. Correlates of marijuana drugged driving and openness to driving while high. Evidence from Colorado and Washington: PLoS ONE. 2016;11:e0146853.
42. Denial of application for licensure or renewal, or issuance of conditional license, Cal Bus. & Prof. Code § 19323.
43. Drug Policy Alliance. Proposition 64: a guide to resentencing and reclassification. http://www.drugpolicy.org/sites/default/files/Prop_64_resentencing_guide.pdf. Accessed March 22, 2017.
44. Wallace BC., Controversies in knowledge translation for community-based drug treatment: the need to the end policies of the war on drugs and mass incarceration of drug offenders to achieve health equity. J Urban Health. 2012;89:894–904.
45. Welch VA, Petticrew M, O’Neill J. Health equity: evidence synthesis and knowledge translation methods. Syst Rev. 2013;2:43.
46. Ramchand R, Pacula RL, Iguchi MY., Racial differences in marijuana-users’ risk of arrest in the United States. Drug Alcohol Depend. 2006;84:264–272.
47. Mitchell O, Caudy MS., Race differences in drug offending and drug distribution arrests. Crime Delinquency. 2015;63:91–112.
48. Brook JS, Lee JY, Finch SJ, Seltzer N, Brook DW., Adult work commitment, financial stability, and social environment as related to trajectories of marijuana use beginning in adolescence. Subst Abus. 2013;34:298–305.
49. United States v. McIntosh, filed 8/16/16. https://cdn.ca9.uscourts.gov/datastore/opinions/2016/08/16/15-10117.pdf. Accessed March 22, 2017.
50. Congressional Cannabis Caucus. Executive summary of the path to marijuana reform. https://www.finance.senate.gov/imo/media/doc/(1)%20Path%20to%20Marijuana%20Reform%20Executive%20Summary.pdf. Accessed March 22, 2017.
51. Carter OB, Mills BW, Donovan RJ., The effect of retail cigarette pack displays on unplanned purchases: results from immediate postpurchase interviews. Tob Control. 2009;18:218–221.
52. Lee DC, Crosier BS, Borodovsky JT, Sargent JD, Budney AJ., Online survey characterizing vaporizer use among cannabis users. Drug Alcohol Depend. 2016;159:227–233.
53. Schauer GL, King BA, Bunnell RE, Promoff G, McAfee TA., Toking, vaping, and eating for health or fun. Am J Prev Med. 2016;50:1–8.